Everolimus-Based Immunosuppression in Liver Transplant Recipients

被引:2
作者
Saliba, F. [1 ]
机构
[1] Hop Paul Brousse, AP HP, Ctr Hepatobiliaire, INSERM,Unite 1193, Villejuif, France
关键词
D O I
10.1111/ajt.14388
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:2489 / 2489
页数:1
相关论文
共 3 条
  • [1] Cholongitas E., 2017, AM J TRANSPLANT
  • [2] A Randomized, Controlled Study to Assess the Conversion From Calcineurin-Inhibitors to Everolimus After Liver Transplantation - PROTECT
    Fischer, L.
    Klempnauer, J.
    Beckebaum, S.
    Metselaar, H. J.
    Neuhaus, P.
    Schemmer, P.
    Settmacher, U.
    Heyne, N.
    Clavien, P-A
    Muehlbacher, F.
    Morard, I.
    Wolters, H.
    Vogel, W.
    Becker, T.
    Sterneck, M.
    Lehner, F.
    Klein, C.
    Kazemier, G.
    Pascher, A.
    Schmidt, J.
    Rauchfuss, F.
    Schnitzbauer, A.
    Nadalin, S.
    Hack, M.
    Ladenburger, S.
    Schlitt, H. J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (07) : 1855 - 1865
  • [3] Efficacy and Safety of Everolimus and Mycophenolic Acid With Early Tacrolimus Withdrawal After Liver Transplantation: A Multicenter Randomized Trial
    Saliba, F.
    Duvoux, C.
    Gugenheim, J.
    Kamar, N.
    Dharancy, S.
    Salame, E.
    Neau-Cransac, M.
    Durand, F.
    Houssel-Debry, P.
    Vanlemmens, C.
    Pageaux, G.
    Hardwigsen, J.
    Eyraud, D.
    Calmus, Y.
    Di Giambattista, F.
    Dumortier, J.
    Conti, F.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (07) : 1843 - 1852